BHC - Sol-Gel Technologies: A Promising Small-Cap Dermatology Player In 2020
Today, we will see why Sol-Gel Technologies (SLGL) is a promising small-cap dermatology pick for 2020.
Company overview
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on becoming leaders in the treatment of acne and rosacea. Sol-Gel Technologies has two investigational branded products, TWIN and Epsolay, as well as multiple generic product candidates targeting a range of dermatology indications.
What differentiates Sol-Gel’s technology platform?
Sol-Gel Technologies has developed a silica-based microencapsulation delivery system through proprietary chemical processes called ‘sol-gel.’
This technology is used to encapsulate active pharmaceutical ingredients and deliver them under